Pré-eclâmpsia

American College of Obstetricians and Gynecologists. Practice bulletin no. 222: gestational hypertension and preeclampsia. Jun 2020 [internet publication].Texto completo

Magee LA, Brown MA, Hall DR, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022 Mar;27:148-69. Resumo

National Institute for Health and Care Excellence. Hypertension in pregnancy: diagnosis and management. Apr 2023 [internet publication].Texto completo

Poon LC, Shennan A, Hyett JA, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019 May;145 Suppl 1:1-33.Texto completo  Resumo

National Institute for Health and Care Excellence. PLGF-based testing to help diagnose suspected preterm pre-eclampsia. Jul 2022 [internet publication].Texto completo

1. American College of Obstetricians and Gynecologists. Practice bulletin no. 222: gestational hypertension and preeclampsia. Jun 2020 [internet publication].Texto completo

2. Magee LA, Brown MA, Hall DR, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022 Mar;27:148-69. Resumo

3. Steegers EA, von Dadelszen P, Duvekot JJ, et al. Pre-eclampsia. Lancet. 2010 Aug 21;376(9741):631-44. Resumo

4. Tuffnell DJ, Jankowicz D, Lindow SW, et al. Outcomes of severe pre-eclampsia/eclampsia in Yorkshire 1999/2003. BJOG. 2005 Jul;112(7):875-80.Texto completo  Resumo

5. Ngwenya S. Severe preeclampsia and eclampsia: incidence, complications, and perinatal outcomes at a low-resource setting, Mpilo Central Hospital, Bulawayo, Zimbabwe. Int J Womens Health. 2017 May 17;9:353-7.Texto completo  Resumo

6. Osungbade KO, Ige OK. Public health perspectives of preeclampsia in developing countries: implication for health system strengthening. J Pregnancy. 2011;2011:481095.Texto completo  Resumo

7. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol. 2002 Sep;2(9):656-63. Resumo

8. Chappell LC, Cluver CA, Kingdom J, et al. Pre-eclampsia. Lancet. 2021 Jul 24;398(10297):341-54. Resumo

9. Desoye G, Hauguel-de Mouzon S. The human placenta in gestational diabetes mellitus: the insulin and cytokine network. Diabetes Care. 2007 Jul;30 Suppl 2:S120-6.Texto completo  Resumo

10. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005 Mar 12;330(7491):565.Texto completo  Resumo

11. Brew O, Sullivan MH, Woodman A. Comparison of normal and pre-eclamptic placental gene expression: a systematic review with meta-analysis. PLoS One. 2016 Aug 25;11(8):e0161504.Texto completo  Resumo

12. Duhig K, Vandermolen B, Shennan A. Recent advances in the diagnosis and management of pre-eclampsia. F1000Res. 2018 Feb 28;7:242.Texto completo  Resumo

13. Smith TA, Kirkpatrick DR, Kovilam O, et al. Immunomodulatory role of vitamin D in the pathogenesis of preeclampsia. Expert Rev Clin Immunol. 2015;11(9):1055-63.Texto completo  Resumo

14. de Haas S, Ghossein-Doha C, van Kuijk SM, et al. Physiological adaptation of maternal plasma volume during pregnancy: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2017 Feb;49(2):177-87. Resumo

15. MBRRACE-UK; Knight M, Bunch K, Tuffnell D, et al. Saving lives, improving mothers’ care: lessons learned to inform maternity care from the UK and Ireland confidential enquiries into maternal deaths and morbidity 2015-17. November 2019 [internet publication].Texto completo

16. National Institute for Health and Care Excellence. Hypertension in pregnancy: diagnosis and management. Apr 2023 [internet publication].Texto completo

17. Deen ME, Ruurda LG, Wang J, et al. Risk factors for preeclampsia in multiparous women: primipaternity versus the birth interval hypothesis. J Matern Fetal Neonatal Med. 2006 Feb;19(2):79-84. Resumo

18. Redman CW, Sargent IL. Placental debris, oxidative stress and pre-eclampsia. Placenta. 2000 Sep;21(7):597-602. Resumo

19. Hernández-Díaz S, Toh S, Cnattingius S. Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ. 2009 Jun 18;338:b2255.Texto completo  Resumo

20. Poon LC, Shennan A, Hyett JA, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019 May;145 Suppl 1:1-33.Texto completo  Resumo

21. GOPEC Consortium. Disentangling fetal and maternal susceptibility for pre-eclampsia: a British multicenter candidate-gene study. Am J Hum Genet. 2005 Jul;77(1):P127-31.Texto completo  Resumo

22. Lin Y, Wang L, Yan Y, et al. A meta-analysis of tumor necrosis factor-α and FAS/FASL polymorphisms with risk of pre-eclampsia. Hypertens Pregnancy. 2019 Feb;38(1):20-31. Resumo

23. Poorolajal J, Jenabi E. The association between body mass index and preeclampsia: a meta-analysis. J Matern Fetal Neonatal Med. 2016 Nov;29(22):3670-6. Resumo

24. Spradley FT. Metabolic abnormalities and obesity's impact on the risk for developing preeclampsia. Am J Physiol Regul Integr Comp Physiol. 2017 Jan 1;312(1):R5-12.Texto completo  Resumo

25. Khalil A, Syngelaki A, Maiz N, et al. Maternal age and adverse pregnancy outcome: a cohort study. Ultrasound Obstet Gynecol. 2013 Dec;42(6):634-43.Texto completo  Resumo

26. American College of Obstetricians and Gynecologists. Pregnancy at age 35 years or older. Aug 2022 [internet publication].Texto completo

27. American College of Obstetricians and Gynecologists. Practice bulletin no. 231:​ multifetal gestations twin triplet and higher-order multifetal pregnancies. Jun 2021 [internet publication].Texto completo

28. DoPierala AL, Bhatta S, Raja EA, et al. Obstetric consequences of subfertility: a retrospective cohort study. BJOG. 2016 Jul;123(8):1320-8. Resumo

29. Schwarze JE, Borda P, Vásquez P, et al. Is the risk of preeclampsia higher in donor oocyte pregnancies? A systematic review and meta-analysis. JBRA Assist Reprod. 2018 Mar 1;22(1):15-19.Texto completo  Resumo

30. American College of Obstetricians and Gynecologists. Headaches in pregnancy and postpartum. May 2022 [internet publication].Texto completo

31. Aukes AM, Yurtsever FN, Boutin A, et al. Associations between migraine and adverse pregnancy outcomes: systematic review and meta-analysis. Obstet Gynecol Surv. 2019 Dec;74(12):738-48. Resumo

32. Facchinetti F, Allais G, Nappi RE, et al. Migraine is a risk factor for hypertensive disorders in pregnancy: a prospective cohort study. Cephalalgia. 2009 Mar;29(3):286-92. Resumo

33. Yu HF, Chen HS, Rao DP, et al. Association between polycystic ovary syndrome and the risk of pregnancy complications: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2016 Dec;95(51):e4863.Texto completo  Resumo

34. Wiles K, Chappell L, Clark K, et al. Clinical practice guideline on pregnancy and renal disease. BMC Nephrol. 2019 Oct 31;20(1):401.Texto completo  Resumo

35. Bramham K, Briley AL, Seed PT, et al. Pregnancy outcome in women with chronic kidney disease: a prospective cohort study. Reprod Sci. 2011 Jul;18(7):623-30. Resumo

36. Palma-Reis I, Vais A, Nelson-Piercy C, et al. Renal disease and hypertension in pregnancy. Clin Med (Lond). 2013 Feb;13(1):57-62.Texto completo  Resumo

37. Seely EW, Ecker J. Chronic hypertension in pregnancy. Circulation. 2014 Mar 18;129(11):1254-61.Texto completo  Resumo

38. Palmer SK, Moore LG, Young D, et al. Altered blood pressure course during normal pregnancy and increased preeclampsia at high altitude (3100 meters) in Colorado. Am J Obstet Gynecol. 1999 May;180(5):1161-8. Resumo

39. Businge CB, Usenbo A, Longo-Mbenza B, et al. Insufficient iodine nutrition status and the risk of pre-eclampsia: a systemic review and meta-analysis. BMJ Open. 2021 Feb 10;11(2):e043505.Texto completo  Resumo

40. Toloza FJK, Derakhshan A, Männistö T, et al. Association between maternal thyroid function and risk of gestational hypertension and pre-eclampsia: a systematic review and individual-participant data meta-analysis. Lancet Diabetes Endocrinol. 2022 Apr;10(4):243-52.Texto completo  Resumo

41. Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017 Aug 17;377(7):613-22.Texto completo  Resumo

42. Duley L, Meher S, Hunter KE, et al. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD004659.Texto completo  Resumo

43. American College of Obstetricians and Gynecologists. Committee opinion no. 743: low-dose aspirin use during pregnancy​. Jul 2018 [internet publication].Texto completo

44. Roberge S, Villa P, Nicolaides K, et al. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther. 2012;31(3):141-6.Texto completo  Resumo

45. Roberge S, Bujold E, Nicolaides KH. Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 2018 Mar;218(3):287-93.Texto completo  Resumo

46. Barakat R, Pelaez M, Cordero Y, et al. Exercise during pregnancy protects against hypertension and macrosomia: randomized clinical trial. Am J Obstet Gynecol. 2016 May;214(5):649. Resumo

47. Davenport MH, Ruchat SM, Poitras VJ, et al. Prenatal exercise for the prevention of gestational diabetes mellitus and hypertensive disorders of pregnancy: a systematic review and meta-analysis. Br J Sports Med. 2018 Nov;52(21):1367-75. Resumo

48. Hofmeyr GJ, Lawrie TA, Atallah ÁN, et al. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2018 Oct 1;(10):CD001059.Texto completo  Resumo

49. World Health Organization. WHO recommendation on calcium supplementation during pregnancy for the prevention of pre-eclampsia and its complications. 2020 [internet publication].Texto completo

50. Villar J, Abdel-Aleem H, Merialdi M, et al; World Health Organization Calcium Supplementation for the Prevention of Preeclampsia Trial Group. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol. 2006 Mar;194(3):639-49.Texto completo  Resumo

51. Hofmeyr GJ, Manyame S, Medley N, et al. Calcium supplementation commencing before or early in pregnancy, for preventing hypertensive disorders of pregnancy. Cochrane Database Syst Rev. 2019 Sep 16;(9):CD011192.Texto completo  Resumo

52. Palacios C, Kostiuk LK, Peña-Rosas JP. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev. 2019 Jul 26;(7):CD008873.Texto completo  Resumo

53. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 1988 Apr;158(4):892-8. Resumo

54. Society of Obstetric Medicine of Australia and New Zealand. Hypertension in pregnancy guideline. 2023 [internet publication].Texto completo

55. Tourigny C, Rey E, Moreau J, et al. Albumin/creatinine ratio for the detection of significant proteinuria of preeclampsia in hospitalized hypertensive women. J Obstet Gynaecol Canada. 2021 May 1;43(5):576-82.

56. National Institute for Health and Care Excellence. PLGF-based testing to help diagnose suspected preterm pre-eclampsia. Jul 2022 [internet publication].Texto completo

57. Hurrell A, Webster L, Sparkes J, et al. Repeat placental growth factor-based testing in women with suspected preterm pre-eclampsia (PARROT-2): a multicentre, parallel-group, superiority, randomised controlled trial. Lancet. 2024 Feb 17;403(10427):619-31. Resumo

58. Duhig KE, Myers J, Seed PT, et al. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial. Lancet. 2019 May 4;393(10183):1807-18.Texto completo  Resumo

59. Cerdeira AS, O'Sullivan J, Ohuma EO, et al. Randomized interventional study on prediction of preeclampsia/eclampsia in women with suspected preeclampsia: INSPIRE. Hypertension. 2019 Oct;74(4):983-90.Texto completo  Resumo

60. Duhig KE, Myers JE, Gale C, et al. Placental growth factor measurements in the assessment of women with suspected preeclampsia: a stratified analysis of the PARROT trial. Pregnancy Hypertens. 2021 Mar;23:41-7.Texto completo  Resumo

61. Simundic AM, Bölenius K, Cadamuro J, et al. Joint EFLM-COLABIOCLI recommendation for venous blood sampling. Clin Chem Lab Med 2018;56(12):2015-38. Resumo

62. Eastwood KA, Patterson C, Hunter AJ, et al. Evaluation of the predictive value of placental vascularisation indices derived from 3-dimensional power Doppler whole placental volume scanning for prediction of pre-eclampsia: a systematic review and meta-analysis. Placenta. 2017 Mar;51:89-97. Resumo

63. von Dadelszen P, Payne B, Li J, et al; PIERS Study Group. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet. 2011 Jan 15;377(9761):219-27. Resumo

64. Thangaratinam S, Allotey J, Marlin N, et al. Development and validation of Prediction models for Risks of complications in Early-onset Pre-eclampsia (PREP): a prospective cohort study. Health Technol Assess. 2017 Apr;21(18):1-100.Texto completo  Resumo

65. U.S. Preventive Services Task Force. Final recommendation statement: hypertensive disorders of pregnancy: screening​. Sep 2023 [internet publication].Texto completo

66. Sotiriadis A, Hernandez-Andrade E, da Silva Costa F, et al; ISUOG CSC Pre-eclampsia Task Force. ISUOG practice guidelines: role of ultrasound in screening for and follow-up of pre-eclampsia. Ultrasound Obstet Gynecol. 2019 Jan;53(1):7-22.Texto completo  Resumo

67. Bartsch E, Medcalf KE, Park AL, et al. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. 2016 Apr 19;353:i1753.Texto completo  Resumo

68. Kuc S, Wortelboer EJ, van Rijn BB, et al. Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review. Obstet Gynecol Surv. 2011 Apr;66(4):225-39. Resumo

69. Skråstad RB, Hov GG, Blaas HG, et al. Risk assessment for preeclampsia in nulliparous women at 11-13 weeks gestational age: prospective evaluation of two algorithms. BJOG. 2015 Dec;122(13):1781-8.Texto completo  Resumo

70. Rolnik DL, Wright D, Poon LCY, et al. ASPRE trial: performance of screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol. 2017 Oct;50(4):492-5.Texto completo  Resumo

71. van Baaren GJ, Broekhuijsen K, van Pampus MG, et al. An economic analysis of immediate delivery and expectant monitoring in women with hypertensive disorders of pregnancy, between 34 and 37 weeks of gestation (HYPITAT-II). BJOG. 2017 Feb;124(3):453-61.Texto completo  Resumo

72. Churchill D, Duley L, Thornton JG, et al. Interventionist versus expectant care for severe pre-eclampsia between 24 and 34 weeks' gestation. Cochrane Database Syst Rev. 2018 Oct 5;(10):CD003106.Texto completo  Resumo

73. Publications Committee, Society for Maternal-Fetal Medicine; Sibai BM. Evaluation and management of severe preeclampsia before 34 weeks' gestation. Am J Obstet Gynecol. 2011 Sep;205(3):191-8.Texto completo  Resumo

74. American College of Obstetricians and Gynecologists. Committee opinion no. 455: magnesium sulfate before anticipated preterm birth for neuroprotection. Mar 2010 [internet publication].Texto completo

75. Broekhuijsen K, van Baaren GJ, van Pampus MG, et al; HYPITAT-II study group. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial. Lancet. 2015 Jun 20;385(9986):2492-501. Resumo

76. Koopmans CM, Bijlenga D, Groen H, et al; HYPITAT Study Group. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009 Sep 19;374(9694):979-88. Resumo

77. Cluver C, Novikova N, Koopmans CM, et al. Planned early delivery versus expectant management for hypertensive disorders from 34 weeks gestation to term. Cochrane Database Syst Rev. 2017 Jan 15;(1):CD009273.Texto completo  Resumo

78. Chappell LC, Brocklehurst P, Green ME, et al. Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial. Lancet. 2019 Sep 28;394(10204):1181-90.Texto completo  Resumo

79. Hein HA. Cardiorespiratory arrest with laryngeal oedema in pregnancy-induced hypertension. Can Anaesth Soc J. 1984 Mar;31(2):210-2. Resumo

80. Shekhar S, Gupta N, Kirubakaran R, et al. Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis. BJOG. 2016 Jan;123(1):40-7.Texto completo  Resumo

81. Moodley J, Soma-Pillay P, Buchmann E, et al. Hypertensive disorders in pregnancy: 2019 national guideline. S Afr Med J. 2019 Sep 13;109(9):12723.Texto completo  Resumo

82. American College of Obstetricians and Gynecologists. Practice bulletin no. 203: chronic hypertension in pregnancy. Jan 2019 [internet publication].Texto completo

83. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet. 1995 Jun 10;345(8963):1455-63. Resumo

84. Medicines and Healthcare products Regulatory Agency. Magnesium sulfate: risk of skeletal adverse effects in the neonate following prolonged or repeated use in pregnancy. May 2019 [internet publication].Texto completo

85. US Food and Drug Administration. FDA drug safety communication: FDA recommends against prolonged use of magnesium sulfate to stop preterm labor due to bone changes in exposed babies. May 2013 [internet publication].Texto completo

86. Kusminsky RE. Complications of central venous catheterization. J Am Coll Surg. 2007 Apr;204(4):681-96.Texto completo  Resumo

87. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. 2003 Mar 20;348(12):1123-33.Texto completo  Resumo

88. Smith RN, Nolan JP. Central venous catheters. BMJ. 2013 Nov 11;347:f6570.Texto completo  Resumo

89. Reich DL. Monitoring in anesthesia and perioperative care. Cambridge: Cambridge University Press; 2011.

90. Abbott Northwestern Hospital Internal Medicine Residency. Internal jugular central venous line. 2022 [internet publication].Texto completo

91. Bishop L, Dougherty L, Bodenham A, et al. Guidelines on the insertion and management of central venous access devices in adults. Int J Lab Hematol. 2007 Aug;29(4):261-78.Texto completo  Resumo

92. Practice guidelines for central venous access 2020: an updated report by the American Society of Anesthesiologists Task Force on Central Venous Access. Anesthesiology. 2020 Jan;132(1):8-43.Texto completo  Resumo

93. Fletcher SJ, Bodenham AR. Safe placement of central venous catheters: where should the tip of the catheter lie? Br J Anaesth. 2000 Aug;85(2):188-91.Texto completo

94. Gibson F, Bodenham A. Misplaced central venous catheters: applied anatomy and practical management. Br J Anaesth. 2013 Mar;110(3):333-46.Texto completo

95. Schuster M, Nave H, Piepenbrock S, et al. The carina as a landmark in central venous catheter placement. Br J Anaesth. 2000 Aug;85(2):192-4.Texto completo

96. Conrad KP. G-protein-coupled receptors as potential drug candidates in preeclampsia: targeting the relaxin/insulin-like family peptide receptor 1 for treatment and prevention. Hum Reprod Update. 2016 Sep;22(5):647-64.Texto completo  Resumo

97. Paauw ND, Terstappen F, Ganzevoort W, et al. Sildenafil during pregnancy: a preclinical meta-analysis on fetal growth and maternal blood pressure. Hypertension. 2017 Nov;70(5):998-1006. Resumo

98. Sibley CP. Treating the dysfunctional placenta. J Endocrinol. 2017 Aug;234(2):R81-97.Texto completo  Resumo

99. Heida KY, Bots ML, de Groot CJ, et al. Cardiovascular risk management after reproductive and pregnancy-related disorders: a Dutch multidisciplinary evidence-based guideline. Eur J Prev Cardiol. 2016 Nov;23(17):1863-79. Resumo

100. Wang Z, Wang Z, Wang L, et al. Hypertensive disorders during pregnancy and risk of type 2 diabetes in later life: a systematic review and meta-analysis. Endocrine. 2017 Mar;55(3):809-21. Resumo

101. Benschop L, Duvekot JJ, Versmissen J, et al. Blood pressure profile 1 year after severe preeclampsia. Hypertension. 2018 Mar;71(3):491-8. Resumo

102. Brouwers L, van der Meiden-van Roest AJ, Savelkoul C, et al. Recurrence of pre-eclampsia and the risk of future hypertension and cardiovascular disease: a systematic review and meta-analysis. BJOG. 2018 Dec;125(13):1642-54.Texto completo  Resumo

103. Stuart JJ, Tanz LJ, Missmer SA, et al. Hypertensive disorders of pregnancy and maternal cardiovascular disease risk factor development: an observational cohort study. Ann Intern Med. 2018 Aug 21;169(4):224-32. Resumo

104. Kristensen JH, Basit S, Wohlfahrt J, et al. Pre-eclampsia and risk of later kidney disease: nationwide cohort study. BMJ. 2019 Apr 29;365:l1516.Texto completo  Resumo

105. Khashan AS, Evans M, Kublickas M, et al. Preeclampsia and risk of end stage kidney disease: a Swedish nationwide cohort study. PLoS Med. 2019 Jul;16(7):e1002875.Texto completo  Resumo

106. Behrens I, Basit S, Melbye M, et al. Risk of post-pregnancy hypertension in women with a history of hypertensive disorders of pregnancy: nationwide cohort study. BMJ. 2017 Jul 12;358:j3078.Texto completo  Resumo

107. Parikh NI, Gonzalez JM, Anderson CAM, et al. Adverse pregnancy outcomes and cardiovascular disease risk: unique opportunities for cardiovascular disease prevention in women – a scientific statement from the American Heart Association. Circulation. 2021 May 4;143(18):e902-16.Texto completo  Resumo

108. O'Kelly AC, Michos ED, Shufelt CL, et al. Pregnancy and reproductive risk factors for cardiovascular disease in women. Circ Res. 2022 Feb 18;130(4):652-72.Texto completo  Resumo

109. Boucheron P, Lailler G, Moutengou E, et al. Hypertensive disorders of pregnancy and onset of chronic hypertension in France: the nationwide CONCEPTION study. Eur Heart J. 2022 Sep 14;43(35):3352-61.Texto completo  Resumo

110. Grandi SM, Filion KB, Yoon S, et al. Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications. Circulation. 2019 Feb 19;139(8):1069-79.Texto completo  Resumo

111. Wenger NK, Lloyd-Jones DM, Elkind MSV, et al. Call to action for cardiovascular disease in women: epidemiology, awareness, access, and delivery of equitable health care: a presidential advisory from the American Heart Association. Circulation. 2022 Jun 7;145(23):e1059-71.Texto completo  Resumo

112. Miller EC, Gatollari HJ, Too G, et al. Risk factors for pregnancy-associated stroke in women with preeclampsia. Stroke. 2017 Jul;48(7):1752-9.Texto completo  Resumo

113. Haug EB, Horn J, Markovitz AR, et al. Life course trajectories of cardiovascular risk factors in women with and without hypertensive disorders in first pregnancy: The HUNT Study in Norway. J Am Heart Assoc. 2018 Aug 7;7(15):e009250.Texto completo  Resumo

114. Stuart JJ, Tanz LJ, Cook NR, et al. Hypertensive disorders of pregnancy and 10-year cardiovascular risk prediction. J Am Coll Cardiol. 2018 Sep 11;72(11):1252-63.Texto completo  Resumo

115. Dodd JM, McLeod A, Windrim RC, et al. Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. Cochrane Database Syst Rev. 2013 Jul 24;(7):CD006780.Texto completo  Resumo

116. Roberge S, Demers S, Nicolaides KH, et al. Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis. Ultrasound Obstet Gynecol. 2016 May;47(5):548-53.Texto completo  Resumo